ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $0 | – | 7 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |